BLADDER CANCER TUMOR MARKER, ANTIBIOTIC AND APPLICATION THEREOF
摘要
Provided in the present invention are an aberrant glycosylation integrin, AG-aß1, and a use thereof as a bladder cancer marker. Also provided in the present invention are an anti-AG-aß1 hybridoma monoclonal antibody, a monoclonal antibody BCMabl as a secretion thereof, and a use of BCMabl in the preparation of a medicament for the treatment of bladder cancer. Also provided in the present invention is a use of an inhibitor of GAL3ST2 and N-acetylgalactosaminyltransferase 1 in the preparation of the medicament for the treatment of bladder cancer.
申请公布号
WO2012019437(A1)
申请公布日期
2012.02.16
申请号
WO2011CN01345
申请日期
2011.08.12
申请人
INSTITUTE OF BIOPHYSICS, CHINESE ACADEMY OF SCIENCES;LI, CHONG;FAN, ZUSEN;ZHANG, HONGLIAN;DAI, ZHONGHUA;TANG, HAIDONG;CHEN, JUN
发明人
LI, CHONG;FAN, ZUSEN;ZHANG, HONGLIAN;DAI, ZHONGHUA;TANG, HAIDONG;CHEN, JUN
